Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

BACKGROUND: Although the introduction of novel agents improved the survival outcomes in patients with multiple myeloma (MM), some patients died within one year (early mortality, EM) following diagnosis. In this study, we evaluated the EM rate, and investigated the risk factors associated with EM in...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:BMC Cancer
Hoofdauteurs: Jung, Sung-Hoon, Cho, Min-Seok, Kim, Hee Kyung, Kim, Seok Jin, Kim, Kihyun, Cheong, June-Won, Kim, Soo-Jeoong, Kim, Jin Seok, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2016
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4977683/
https://ncbi.nlm.nih.gov/pubmed/27501959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2645-y
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items